A rare lupus randomization, among the first worldwide

Lupus is one of the most complex diseases in clinical research, and in many studies the hardest step is not enrollment but randomization. In one global lupus study, only three patients had been randomized worldwide, and Stryde recently achieved one of them in the U.S.

Milestones like this come down to execution. We are proud of our Operations and Recruitment teams for making it possible, and for showing what focused, physician-led sites can deliver on the studies that matter most to sponsors.

All news